A Prospective Observational Cohort Study of Predictive Factors Related to Prognosis of In-hosiptal Patients With Ischemic Stroke Due to Large-artery Atherosclerosis

Status: Recruiting
Location: See location...
Intervention Type: Drug, Procedure
Study Type: Observational
SUMMARY

This is a single-center prospective cohort study of predictive factors related to prognosis of ischemic stroke due to large-artery atherosclerosis. From March 1, 2021 to December 31, 2026, 1000 patients with ischemic stroke due to large-artery atherosclerosis who are admitted to the Department of Neurology or Neurosurgery, Tongji Hospital are going to be recruited. Detailed clinical data in emergency room and in-hospital will be obtained from the medical record reviews, and the National Institutes of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) score will be done by certified neurologists to assess the severity of the disease in acute stage and treatment outcome during the follow-up. All cases will undergo routine blood tests, brain magnetic resonance imaging (MRI) and cerebral vascular examination, such as TCD, CTA, HRMR or DSA. The investigators will analyze the in-hospital factors that could predict the outcome to provide more evidence-based suggestions in the treatment and prognosis of atherosclerotic ischemic cerebrovascular disease.

Eligibility
Participation Requirements
Sex: All
Maximum Age: 80
Healthy Volunteers: f
View:

• Ischemic stroke due to large-artery atherosclerosis has been proved by clinical symptoms and imaging examinations.

• Symptomatic superior arch stenosis \>50%

• Asymptomatic superior arch stenosis was \>70%

• written informed consent was obtained from patients or their surrogates before enrollment.

Locations
Other Locations
China
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITING
Wuhan
Contact Information
Primary
Dai-Shi Tian, Dr.
tiands@tjh.tjmu.edu.cn
86-27-83663337
Backup
Chuan Qin, Dr.
qinchuan712@126.com
86-27-83663337
Time Frame
Start Date: 2021-03-01
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 1000
Sponsors
Leads: Tongji Hospital

This content was sourced from clinicaltrials.gov